Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
39.8M
-
Shares change
-
-720K
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
-$35.2M
-
Put/Call ratio
-
0.59
-
Number of buys
-
98
-
Number of sells
-
-90
-
Price
-
$43.02
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2018
239 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2018.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.8M shares
of 44.9M outstanding shares and own 88.79% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (3.79M shares), Consonance Capital Management LP (3.65M shares), BlackRock Inc. (3.33M shares), HealthCor Management, L.P. (2.5M shares), MACQUARIE GROUP LTD (2.14M shares), Rock Springs Capital Management LP (1.25M shares), MILLENNIUM MANAGEMENT LLC (1.22M shares), Stephens Investment Management Group LLC (1.2M shares), Clearbridge Investments, LLC (1.15M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.08M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.